Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

China · Delayed Price · Currency is CNY

10.53

+0.21 (2.03%)

Oct 23, 2026, 3:04 PM CST

Market Cap	5.20B -37.8%
Revenue (ttm)	2.89B -6.2%
Net Income	341.06M -34.4%
EPS	0.76 -26.0%
Shares Out	494.11M
PE Ratio	13.77
Forward PE	10.22
Dividend	0.40 (3.80%)
Ex-Dividend Date	May 28, 2026

Volume	5,365,196
Open	10.80
Previous Close	10.32
Day's Range	10.08 - 10.80
52-Week Range	9.26 - 17.37
Beta	-0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About SHE:300705

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers chemical drug preparations, active pharmaceutical ingredients (APIs), pharmaceutical excipients, traditional Chinese medicine, health foods, and rehabilitation and wellness products. Its products portfolio includes loxoprofen sodium gel patches, ketoprofen gel patches, pantopril sodium enteric-coated tablets, dapagliflozin tablets, and rosuvastatin calcium. It also provides digestive system an... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2001

Employees 2,298

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300705

Full Company Profile

Financial Performance

In 2025, SHE:300705's revenue was 3.11 billion, an increase of 6.15% compared to the previous year's 2.93 billion. Earnings were 472.82 million, a decrease of -7.72%.

Financial Statements